Start Your NewsReadery Pro FREE TRIAL!
Register and verify your email address to start your
NewsReadery Pro FREE TRIAL
today!
Login / Register
Actions
Newsfeed
Popular
Local
Discover
Follows
Blocks
Bookmarks
Filters
Settings
PowerUps
Help
Updates
Login / Register
zacks.com
/
Share Newsitem
View, share or embed this newsitem using the details below.
Zacks Investment Research: Stock Research, Analysis, & Recommendations
@zacks.com
/
2 days
2d
Follow
Intellia Crashes 60% in a Year: How Should You Play the Stock?
NTLA stock is down significantly in 2024 as investors are not pleased with the recent data from its in vivo CRISPR-based therapies. We advise prospective investors to stay on the sidelines for now.
https://newsreadery.com/go/0ed46e57da942b8cdcd9e148e2f1f830
Save
Share
Share this Newsitem URL
Embed this Newsitem
<div class="readery-embed readery-embed-0ed46e57da942b8cdcd9e148e2f1f830"></div><script async src="https://open.newsreadery.com/oembed?format=html&url=https%3A%2F%2Fnewsreadery.com%2Fitem%2F0ed46e57da942b8cdcd9e148e2f1f830" charset="utf-8"></script>
Back
Read Full Article
Continue
Please wait ...